GB1326928A - Therapeutic material - Google Patents

Therapeutic material

Info

Publication number
GB1326928A
GB1326928A GB6124070A GB6124070A GB1326928A GB 1326928 A GB1326928 A GB 1326928A GB 6124070 A GB6124070 A GB 6124070A GB 6124070 A GB6124070 A GB 6124070A GB 1326928 A GB1326928 A GB 1326928A
Authority
GB
United Kingdom
Prior art keywords
therapeutic material
precipitation
liquid
subjecting
dec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6124070A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of GB1326928A publication Critical patent/GB1326928A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB6124070A 1969-12-31 1970-12-23 Therapeutic material Expired GB1326928A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6945776A FR2073293B1 (de) 1969-12-31 1969-12-31

Publications (1)

Publication Number Publication Date
GB1326928A true GB1326928A (en) 1973-08-15

Family

ID=9045518

Family Applications (1)

Application Number Title Priority Date Filing Date
GB6124070A Expired GB1326928A (en) 1969-12-31 1970-12-23 Therapeutic material

Country Status (11)

Country Link
JP (1) JPS4940922B1 (de)
AT (1) AT301749B (de)
BE (1) BE760727A (de)
CA (1) CA956573A (de)
CH (1) CH533988A (de)
DE (1) DE2064296C2 (de)
DK (1) DK128054B (de)
FR (1) FR2073293B1 (de)
GB (1) GB1326928A (de)
LU (1) LU62332A1 (de)
NL (1) NL7019097A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027429A2 (de) * 1979-10-11 1981-04-22 Bonifacio Gaetana Verfahren zur Herstellung von Tumorgegenmitteln (Oncoclasinen) aus den Exkrementen von Ziegen

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5330639U (de) * 1976-08-20 1978-03-16
JPS5925332A (ja) * 1982-08-04 1984-02-09 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製法
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027429A2 (de) * 1979-10-11 1981-04-22 Bonifacio Gaetana Verfahren zur Herstellung von Tumorgegenmitteln (Oncoclasinen) aus den Exkrementen von Ziegen
EP0027429A3 (en) * 1979-10-11 1982-05-12 Liborio Dr. Bonifacio Tumor antidote (oncoclasine) for the cure of tumors, and process for its extraction
US4462987A (en) * 1979-10-11 1984-07-31 Liborio Bonifacio Process and composition for treating tumors in mice

Also Published As

Publication number Publication date
BE760727A (fr) 1971-05-27
NL7019097A (de) 1971-07-02
DE2064296A1 (de) 1971-07-15
LU62332A1 (de) 1971-05-27
FR2073293B1 (de) 1973-01-12
JPS4940922B1 (de) 1974-11-06
AT301749B (de) 1972-09-11
DE2064296C2 (de) 1984-10-25
CH533988A (fr) 1973-02-28
FR2073293A1 (de) 1971-10-01
DK128054B (da) 1974-02-25
CA956573A (en) 1974-10-22

Similar Documents

Publication Publication Date Title
Strander et al. Production of human lymphoblastoid interferon
GB1303408A (de)
GB1531762A (en) Cancer antigen cancer therapy and cancer diagnosis
KR900700592A (ko) 용해성 티-4 유도체
GB1267136A (de)
GB1294580A (en) New medicaments derived from nucleic acids, processes for their preparation and their use
GB1499035A (en) Antistaphylococcus human immune globulin and method of preparing same
GB1326928A (en) Therapeutic material
FR2283223A1 (fr) Procede de culture industrielle de sulfuraires en vue, notamment, d'une utilisation dermatologique et cosmetologique
GB1386939A (en) Alkyl esters of alpha-aspartyl alpha-alkyl aliphatic amino acid dipeptides
GB1443948A (en) Production of immunological material
GB1188519A (en) Method for the Purification of Lipopolysaccharides
GB1436529A (en) Process for preparing a blood fraction
Hsu et al. Acinonyx jubatus (cheetah)
ES424506A1 (es) Un sistema para realizar pruebas sanguineas de laboratorio.
ES382051A1 (es) Procedimiento para la preparacion de nuevos esteres y ami- das de acido n-((3-trifluorometilfenil) - antraniloil) - glicolico.
GB1423992A (en) Photosensitive material of biological origin
GB1358321A (en) Method od tissue cell culture
Lafferty et al. A mediator acting as a costimulator for the development of cytotoxic responses in vitro
GB1262147A (en) Antimicrobial factors
BE833079A (fr) Derives n-acyles de l'orgoteine, utiles notamment comme anti-inflammatoires, et leur procede de preparation
FR2059471A1 (en) Heteroploid humas liver epitherial cell - strain as culture for calcination and diagnosis
GB1436323A (en) Cell and virus culture systems
GB1378103A (en) Serological reagent and test for neisseria gonorrhoeae antibodies
GB1290468A (de)

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee